Kevin Han

Kevin Han is a seasoned professional in clinical pharmacology and pharmacometrics, currently serving as Senior Director at Incyte since June 2025. Previously, Kevin held the position of Director and Distinguished Scientist at Johnson & Johnson Innovative Medicine, leading Immuno-Oncology Clinical Pharmacology and managing various I-O programs. Prior to that, Kevin was with Novartis as Senior Principal Scientist, focusing on oncology rare disease portfolios and global clinical pharmacology strategies, and contributed to multiple global new molecular entity submissions. Kevin's career includes significant roles at Bristol-Myers Squibb, where expertise in pharmacokinetics and pharmacodynamics modeling was developed, and early academic research at the University of North Carolina at Chapel Hill, culminating in a PhD in Pharmaceutical Sciences. Additionally, Kevin earned a Master of Science in Medicinal Chemistry from Peking University.